Predictions
Veolia Environnement S.A.
Start price
Target price
Perf. (%)
€32.66
29.12.21
29.12.21
-
29.12.22
29.12.22
-25.96%
30.12.22
30.12.22
Veolia Environnement S.A.
Start price
Target price
Perf. (%)
€32.66
29.12.21
29.12.21
-
29.12.22
29.12.22
-25.96%
30.12.22
30.12.22
BiondVax Pharmaceuticals Ltd ADR
Start price
Target price
Perf. (%)
€22.60
28.12.21
28.12.21
-
28.12.22
28.12.22
-32.74%
07.01.22
07.01.22
Probably not worthwhile Investment
Activision Blizzard Inc.
Start price
Target price
Perf. (%)
€58.25
28.12.21
28.12.21
€80.00
28.12.22
28.12.22
22.23%
28.12.22
28.12.22
Could be worthwhile Investment >10% per year
Fair valuation
High dividend yield expected
Good rating
Activision Blizzard Inc.
Start price
Target price
Perf. (%)
€58.25
28.12.21
28.12.21
€80.00
28.12.22
28.12.22
22.23%
28.12.22
28.12.22
Could be worthwhile Investment >10% per year
Fair valuation
High dividend yield expected
Good rating
Activision Blizzard Inc.
Start price
Target price
Perf. (%)
€58.25
28.12.21
28.12.21
€80.00
28.12.22
28.12.22
22.23%
28.12.22
28.12.22
Could be worthwhile Investment >10% per year
Fair valuation
High dividend yield expected
Good rating
UFP Industries Inc.
Start price
Target price
Perf. (%)
€81.50
28.12.21
28.12.21
€85.00
28.12.22
28.12.22
-8.71%
29.12.22
29.12.22
Could be worthwhile Investment >10% per year
Future proof or reliable business model
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Aalberts Industries NV
Start price
Target price
Perf. (%)
€57.94
28.12.21
28.12.21
€62.00
28.12.22
28.12.22
-36.61%
29.12.22
29.12.22
Could be worthwhile Investment >10% per year
Future proof or reliable business model
ROE lower than 10% per year
Higher risks for its business
Tandem Diabetes Care Inc
Start price
Target price
Perf. (%)
€136.00
28.12.21
28.12.21
€142.00
28.12.22
28.12.22
-70.42%
29.12.22
29.12.22
Could be worthwhile Investment >10% per year
Capable Management
Future proof or reliable business model
Sherwin-Williams Co.
Start price
Target price
Perf. (%)
€307.90
28.12.21
28.12.21
€325.00
28.12.22
28.12.22
-26.91%
28.12.22
28.12.22
Could be worthwhile Investment >10% per year
High dividend yield expected
Good rating
Revenue growth >5% per year expected
Encavis AG
Start price
Target price
Perf. (%)
€15.71
28.12.21
28.12.21
€17.00
28.12.22
28.12.22
-14.58%
06.01.22
06.01.22
Differentiated customer and product portfolio
Standard Investments for future growth
High valuation
Higher risks for its business
Nemetschek SE
Start price
Target price
Perf. (%)
€114.40
28.12.21
28.12.21
€125.00
28.12.22
28.12.22
-18.04%
08.01.22
08.01.22
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
ROE higher than 15% per year
Nemetschek SE
Start price
Target price
Perf. (%)
€114.40
28.12.21
28.12.21
€125.00
28.12.22
28.12.22
-18.04%
08.01.22
08.01.22
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
ROE higher than 15% per year
Wheaton Precious Metals Corp.
Start price
Target price
Perf. (%)
€37.74
28.12.21
28.12.21
-
28.12.22
28.12.22
-10.57%
08.01.22
08.01.22
Could be worthwhile Investment >10% per year
Future proof or reliable business model
Wheaton Precious Metals Corp.
Start price
Target price
Perf. (%)
€37.74
28.12.21
28.12.21
-
28.12.22
28.12.22
-10.57%
08.01.22
08.01.22
Could be worthwhile Investment >10% per year
Future proof or reliable business model
Barrick Gold Corp
Start price
Target price
Perf. (%)
€16.20
28.12.21
28.12.21
-
28.12.22
28.12.22
-0.89%
08.01.22
08.01.22
Could be worthwhile Investment >10% per year
Known brand
Barrick Gold Corp
Start price
Target price
Perf. (%)
€16.20
28.12.21
28.12.21
-
28.12.22
28.12.22
-0.89%
08.01.22
08.01.22
Could be worthwhile Investment >10% per year
Known brand
Kinross Gold Corp.
Start price
Target price
Perf. (%)
€4.97
28.12.21
28.12.21
-
28.12.22
28.12.22
-3.04%
08.01.22
08.01.22
Could be worthwhile Investment >10% per year
Kinross Gold Corp.
Start price
Target price
Perf. (%)
€4.97
28.12.21
28.12.21
-
28.12.22
28.12.22
-3.04%
08.01.22
08.01.22
Could be worthwhile Investment >10% per year
Opko Health Inc.
Start price
Target price
Perf. (%)
€4.65
28.12.21
28.12.21
-
28.12.22
28.12.22
-75.54%
29.12.22
29.12.22
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Innovative
Future proof or reliable business model
Apple Inc.
Start price
Target price
Perf. (%)
€158.82
28.12.21
28.12.21
-
28.12.22
28.12.22
-8.94%
16.11.22
16.11.22
Could be very worthwhile Investment >20% year
